Global Dermatological Therapeutics Market Size study, by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis and Other Applications), by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids and Other

Global Dermatological Therapeutics Market Size study, by Application (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis and Other Applications), by Drug Class (Anti-infectives, Corticosteroids, Anti-acne, Calcineurin Inhibitors, Retinoids and Other Drug Classes) and Regional Forecasts 2022-2028

Global Dermatological Therapeutics Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Rising prevalence of dermatology diseases such as psoriasis, strategic initiatives by market players such as mergers and acquisitions and rising number of clinical trials for dermatology diseases are fueling significant growth in the market. According to the National Clinical Trial Registry, in May 2021, approximately 260 clinical trials were conducted globally for the treatment of psoriasis. Also, in January 2020, Eli Lilly and Company acquired the dermatological drug developer, Dermira, with an investment of USD 1.1 billion, for the addition of commercial and late-stage drugs to its portfolio. Furthermore, rise in aging population and research and development activities by pharmaceutical companies are expected to inject growth in the market in the coming years. According to The World Bank, percentage of the world population 65 years and above increased from 9.102% in 2019 to 9.321% in 2020. However, serious side effects of certain classes of therapeutic drugs may hamper the growth during the forecast period.

Asia Pacific, North America, Europe, Latin America and Rest of the World are considered for regional analysis of the market. North America is leading the global market in terms of revenue owing to increasing healthcare expenditure and growing awareness regarding skin diseases. Whereas, Asia Pacific is expected to grow with the highest growth rate during the forecast period due to rising geriatric population and growing prevalence of skin diseases.

Major market players included in this report are:
Amgen Inc.
Bausch Health Companies Inc.
Novartis AG
AbbVie Inc.
Almirall SA
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Allergan PLC
Pfizer Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Alopecia
Herpes
Psoriasis
Rosacea
Atopic Dermatitis
Other Applications
By Drug Class:
Anti-infectives
Corticosteroids
Anti-acne
Calcineurin Inhibitors
Retinoids
Other Drug Classes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Dermatological Therapeutics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Amgen Inc.
Bausch Health Companies Inc.
Novartis AG
AbbVie Inc.
Almirall SA
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Allergan PLC
Pfizer Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.